1

amgen

05.14.2020

Related Articles

Pharma and MedTech Market Access under a National Health Insurance system

Introduction Pharmaceutical and MedTech market access will look vastly different under a South African national health insurance system. A national health insurance system would result in an integrated healthcare system founded on the principles of solidarity and redistribution of healthcare resources. Every South African would contribute to funding the national health insurance system and in […]

Read all
Regulating private healthcare services in Middle-income Countries

Introduction Private healthcare markets comprise individuals and entities that are not owned or operated by the government. Individuals finance private healthcare services from disposal income, or pooled premium contributions through private health insurance providers. The provision and financing of private healthcare services does not include funding by the government. There are several advantages for patients […]

Read all
Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Introduction Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also […]

Read all
Read all articles